
INCORPORATING II-I RECEPTOR ANTAGONIST SECRETING HEPA-TOCYTES IN A BIOARTIFICIAL LIVER DEVICE FOR THE TREATMENT OF FULMINANT HEPATIC FAILURE
Author(s) -
Masahiro Shinoda,
Arno W. Tilles,
Go Wakabayashi,
Naoya Kobayashi,
François Berthiaume,
Atsushi Takayanagi,
Motohide Shimazu,
Nobuyoshi Shimizu,
Noriaki Tanaka,
Masaki Kitajima,
Ronald G. Tompkins,
Mehmet Toner,
Martin L. Yarmush
Publication year - 2004
Publication title -
asaio journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 66
eISSN - 1538-943X
pISSN - 1058-2916
DOI - 10.1097/00002480-200403000-00229
Subject(s) - fulminant hepatic failure , bioartificial liver device , transfection , hepatocyte , receptor antagonist , antagonist , medicine , hepatic stellate cell , receptor , endocrinology , cytokine , liver injury , cell culture , chemistry , biology , liver transplantation , transplantation , biochemistry , in vitro , genetics